Radiotherapy & Oncology
Volume 92, Issue 1 , Pages 48-56 , July 2009

Endo-rectal balloon cavity dosimetry in a phantom: Performance under IMRT and helical tomotherapy beams

  • Nicholas Hardcastle

      Affiliations

    • Centre for Medical Radiation Physics, University of Wollongong, NSW, Australia
    • Department of Medical Physics, University of Wisconsin – Madison, WI, USA
    • ,
  • Peter E. Metcalfe

      Affiliations

    • Centre for Medical Radiation Physics, University of Wollongong, NSW, Australia
    • ,
  • Anatoly B. Rosenfeld

      Affiliations

    • Centre for Medical Radiation Physics, University of Wollongong, NSW, Australia
    • ,
  • Wolfgang A. Tomé

      Affiliations

    • Department of Human Oncology, University of Wisconsin – Madison, WI, USA
    • Department of Medical Physics, University of Wisconsin – Madison, WI, USA
    • Corresponding Author InformationCorresponding author. Address: Department of Human Oncology, University of Wisconsin – Madison, CSC K4/314, 600 Highland Avenue, Madison, WI 53792, USA.

Received 10 October 2008 ,Revised 3 March 2009 ,Accepted 4 March 2009.

References 

  1. Hanks GE, Hanlon AL, Schultheiss TE, et al. Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys. 1998;41:501–510
  2. Pollack A, Zagars GK, Smith LG, et al. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70Gy with 78Gy for prostate cancer. J Clin Oncol. 2000;18:3904–3911
  3. Zelefsky MJ, Leibel SA, Gaudin PB, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 1998;41:491–500
  4. Marzi S, Arcangeli G, Saracino B, et al. Relationships between rectal wall dose–volume constraints and radiobiologic indices of toxicity for patients with prostate cancer. Int J Radiat Oncol Biol Phys. 2007;68:41–49
  5. Vavassori V, Fiorino C, Rancati T, et al. Predictors for rectal and intestinal acute toxicities during prostate cancer high-dose 3D-CRT: results of a prospective multicenter study. Int J Radiat Oncol Biol Phys. 2007;67:1401–1410
  6. Storey MR, Pollack A, Zagars G, Smith L, Antolak J, Rosen I. Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys. 2000;48:635–642
  7. Tucker SL, Dong L, Cheung R, et al. Comparison of rectal dose-wall histogram versus dose–volume histogram for modeling the incidence of late rectal bleeding after radiotherapy. Int J Radiat Oncol Biol Phys. 2004;60:1589–1601
  8. McGary JE, Teh BS, Butler EB, Grant W. Prostate immobilization using a rectal balloon. J Appl Clin Med Phys. 2002;3:6–11
  9. Patel RR, Orton N, Tome WA, Chappell R, Ritter MA. Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer. Radiother Oncol. 2003;67:285–294
  10. Teh BS, Mai WY, Uhl BM, et al. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose–volume analysis. Int J Radiat Oncol Biol Phys. 2001;49:705–712
  11. van Lin EN, Kristinsson J, Philippens ME, et al. Reduced late rectal mucosal changes after prostate three-dimensional conformal radiotherapy with endorectal balloon as observed in repeated endoscopy. Int J Radiat Oncol Biol Phys. 2007;67:799–811
  12. Wachter S, Gerstner N, Dorner D, et al. The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose–volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2002;52:91–100
  13. D’Amico AV, Manola J, McMahon E, et al. A prospective evaluation of rectal bleeding after dose-escalated three-dimensional conformal radiation therapy using an intrarectal balloon for prostate gland localization and immobilization. Urology. 2006;67:780–784
  14. Sanghani MV, Ching J, Schultz D, et al. Impact on rectal dose from the use of a prostate immobilization and rectal localization device for patients receiving dose escalated 3D conformal radiation therapy. Urol Oncol. 2004;22:165–168
  15. Song JS, Court LE, Cormack RA. Monte Carlo calculation of rectal dose when using an intrarectal balloon during prostate radiation therapy. Med Dosim. 2007;32:151–156
  16. Teh BS, Dong L, McGary JE, Mai WY, Grant W, Butler EB. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer. Med Dosim. 2005;30:25–30
  17. Li XA, Yu C, Holmes T. A systematic evaluation of air cavity dose perturbation in megavoltage X-ray beams. Med Phys. 2000;27:1011–1017
  18. Martens C, Reynaert N, De Wagter C, et al. Underdosage of the upper-airway mucosa for small fields as used in intensity-modulated radiation therapy: a comparison between radiochromic film measurements, Monte Carlo simulations, and collapsed cone convolution calculations. Med Phys. 2002;29:1528–1535
  19. Mackie TR, Scrimger JW, Battista JJ. A convolution method of calculating dose for 15-MV X rays. Med Phys. 1985;12:188–196
  20. Ahnesjo A. Collapsed cone convolution of radiant energy for photon dose calculation in heterogeneous media. Med Phys. 1989;16:577–592
  21. Mackie TR, Bielajew AF, Rogers DW, Battista JJ. Generation of photon energy deposition kernels using the EGS Monte Carlo code. Phys Med Biol. 1988;33:1–20
  22. Hoban PW, Murray DC, Metcalfe PE, Round WH. Superposition dose calculation in lung for 10MV photons. Australas Phys Eng Sci Med. 1990;13:81–92
  23. Woo MK, Cunningham JR. The validity of the density scaling method in primary electron transport for photon and electron beams. Med Phys. 1990;17:187–194
  24. Brenner DJ, Hall EJ. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys. 1999;43:1095–1101
  25. Brenner DJ, Martinez AA, Edmundson GK, Mitchell C, Thames HD, Armour EP. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys. 2002;52:6–13
  26. Fowler J, Chappell R, Ritter M. Is alpha/beta for prostate tumors really low?. Int J Radiat Oncol Biol Phys. 2001;50:1021–1031
  27. Chappell R, Fowler J, Ritter M. New data on the value of alpha/beta – evidence mounts that it is low. Int J Radiat Oncol Biol Phys. 2004;60:1002–1003
  28. King CR, Fowler JF. A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low. Int J Radiat Oncol Biol Phys. 2001;51:213–214
  29. Kupelian PA, Reddy CA, Klein EA, Willoughby TR. Short-course intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2001;51:988–993
  30. Kupelian PA, Willoughby TR, Reddy CA, Klein EA, Mahadevan A. Hypofractionated intensity-modulated radiotherapy (70Gy at 2.5Gy per fraction) for localized prostate cancer: Cleveland Clinic experience. Int J Radiat Oncol Biol Phys. 2007;68:1424–1430
  31. Logue JP, Cowan RA, Hendry JH. Hypofractionation for prostate cancer. Int J Radiat Oncol Biol Phys. 2001;49:1522–1523
  32. Arcangeli S, Strigari L, Soete G, et al. Clinical and dosimetric predictors of acute toxicity after a 4-week hypofractionated external beam radiotherapy regimen for prostate cancer: results from a multicentric prospective trial. Int J Radiat Oncol Biol Phys. 2008;
  33. Leborgne F, Fowler J. Acute toxicity after hypofractionated conformal radiotherapy for localized prostate cancer: nonrandomized contemporary comparison with standard fractionation. Int J Radiat Oncol Biol Phys. 2008;
  34. Paelinck L, Reynaert N, Thierens H, De Neve W, De Wagter C. Experimental verification of lung dose with radiochromic film: comparison with Monte Carlo simulations and commercially available treatment planning systems. Phys Med Biol. 2005;50:2055–2069
  35. Paelinck L, Reynaert N, Thierens H, De Wagter C, De Neve W. The value of radiochromic film dosimetry around air cavities: experimental results and Monte Carlo simulations. Phys Med Biol. 2003;48:1895–1905
  36. International Electrotechnical Commission. IEC1217: Radiotherapy equipment – coordinates, movements and scales; 1996.
  37. Cheung T, Butson MJ, Yu PK. Post-irradiation colouration of Gafchromic EBT radiochromic film. Phys Med Biol. 2005;50:N281–N285
  38. Deasy JO, Blanco AI, Clark VH. CERR: a computational environment for radiotherapy research. Med Phys. 2003;30:979–985
  39. Mackie TR, el-Khatib E, Battista J, Scrimger J, Van Dyk J, Cunningham JR. Lung dose corrections for 6- and 15-MV X rays. Med Phys. 1985;12:327–332
  40. Metcalfe PE, Battista JJ. Accuracy of inhomogeneity corrections in lung irradiated with high energy X-rays. Australas Phys Eng Sci Med. 1988;11:67–75
  41. Metcalfe PE, Wong TP, Hoban PW. Radiotherapy X-ray beam inhomogeneity corrections: the problem of lateral electronic disequilibrium in lung. Australas Phys Eng Sci Med. 1993;16:155–167
  42. Kornelsen RO, Young ME. Changes in the dose-profile of a 10MV X-ray beam within and beyond low density material. Med Phys. 1982;9:114–116
  43. Young ME, Kornelsen RO. Dose corrections for low-density tissue inhomogeneities and air channels for 10-MV X rays. Med Phys. 1983;10:450–455
  44. Massey JB. Dose distribution problems in megavoltage therapy. I. The problem of air spaces. Br J Radiol. 1962;35:736–738
  45. Nilsson B, Schnell PO. Build-up effects at air cavities measured with thin thermoluminescent dosimeters. Acta Radiol Ther Phys Biol. 1976;15:427–432
  46. Wong TP, Metcalfe PE, Kron T, Emeleus TG. Radiotherapy X-ray dose distribution beyond air cavities. Australas Phys Eng Sci Med. 1992;15:138–146
  47. Fiorino C, Cozzarini C, Vavassori V, et al. Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions. Radiother Oncol. 2002;64:1–12
  48. Huang EH, Pollack A, Levy L, et al. Late rectal toxicity: dose–volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2002;54:1314–1321
  49. Jackson A, Skwarchuk MW, Zelefsky MJ, et al. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys. 2001;49:685–698
  50. Boyer A, Mok E. A photon dose distribution model employing convolution calculations. Med Phys. 1985;12:169–177
  51. Mohan R, Chui C, Lidofsky L. Differential pencil beam dose computation model for photons. Med Phys. 1986;13:64–73
  52. Keall PJ, Hoban PW. Superposition dose calculation incorporating Monte Carlo generated electron track kernels. Med Phys. 1996;23:479–485
  53. Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer. 2000;89:1800–1809

PII: S0167-8140(09)00097-8

doi: 10.1016/j.radonc.2009.03.004

Radiotherapy & Oncology
Volume 92, Issue 1 , Pages 48-56 , July 2009

Article Tools

* Image Usage & Resolution